| NCT00264537 | Centocor, Inc.|Schering-Plough | Rheumatoid Arthritis | 2005-12 | PHASE3 |
| NCT01081717 | Janssen Biotech, Inc. | Rheumatoid Arthritis|Arthritis, Psoriatic|Ankylosing Spondylitis | 2009-04-14 | |
| NCT00207714 | Centocor, Inc.|Centocor BV | Rheumatoid Arthritis | 2003-11 | PHASE2 |
| NCT05313620 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Ulcerative Colitis|Thromboembolism | 2022-04-01 | PHASE4 |
| NCT01230827 | Janssen Research & Development, LLC|Schering-Plough | Juvenile Idiopathic Arthritis | 2010-12 | PHASE3 |
| NCT05071664 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2021-10-25 | PHASE2 |
| NCT02728934 | Janssen Scientific Affairs, LLC | Arthritis, Rheumatoid | 2016-02-25 | |
| NCT01871649 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Psoriatic Arthritis | 2013-08 | PHASE3 |
| NCT02758782 | Charite University, Berlin, Germany | Ankylosing Spondylitis | 2016-09 | PHASE4 |
| NCT01863771 | Janssen Pharmaceutical K.K. | Colitis, Ulcerative | 2013-03-15 | PHASE3 |
| NCT01362153 | Centocor, Inc. | Rheumatoid Arthritis | 2007-12-26 | PHASE1 |
| NCT03662542 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2018-11-20 | PHASE2 |
| NCT03182166 | Centre Hospitalier Universitaire de Saint Etienne|Merck Sharp & Dohme LLC | Ulcerative Colitis | 2017-11-21 | PHASE2 |
| NCT02846545 | Janssen Research & Development, LLC | Diabetes Mellitus, Type 1 | 2016-08-26 | PHASE2 |
| NCT03124121 | Guy´s and St Thomas´ NHS Foundation Trust|Merck Sharp & Dohme LLC | Ulcerative Colitis | 2017-09-05 | PHASE4 |
| NCT03016260 | TcLand Expression S.A.|European Commission | RheumatoId Arthritis | 2016-12 | |
| NCT02065713 | Instituto de Medicina Molecular Jo?o Lobo Antunes|Merck Sharp & Dohme LLC | Psoriatic Arthritis | 2014-08 | PHASE3 |
| NCT00675649 | Centocor, Inc. | Asthma | 2008-05 | PHASE2 |
| NCT04156984 | David Drobne | Ulcerative Colitis | 2021-04-07 | PHASE4 |
| NCT05242471 | Janssen Research & Development, LLC | Crohn´s Disease | 2022-07-22 | PHASE2 |
| NCT03270501 | University Ghent|Merck Sharp & Dohme LLC|the Flanders Institute for Biotechnology | Axial Spondyloarthritis | 2017-11-08 | PHASE3 |
| NCT04188249 | Peking Union Medical College Hospital | Arthritis, Rheumatoid | 2019-07-01 | |
| NCT03729349 | Janssen Inc. | Arthritis, Rheumatoid | 2019-01-15 | |
| NCT02412085 | Istituto Clinico Humanitas | Colitis, Ulcerative | 2015-03 | PHASE4 |
| NCT03669029 | Hospital de Manises|General University Hospital of Valencia|Hospital Clínico Universitario de Valencia|Hospital de Sagunto|Hospital Universitario La Fe|Hospital General Universitario de Alicante|Hospital Universitario Doctor Peset|Hospital Arnau de Vilanova|Hospital Provincial de Castellon|Merck Sharp & Dohme LLC | Colitis, Ulcerative | 2018-10-01 | PHASE4 |
| NCT03018925 | Institut d´Investigació Biomèdica de Girona Dr. Josep Trueta | Ulcerative Colitis | 2016-10 | |
| NCT05530122 | Tampere University Hospital | Ulcerative Colitis | 2009-01 | |
| NCT03100253 | Mario Negri Institute for Pharmacological Research | Rheumatoid Arthritis | 2018-03-01 | PHASE4 |
| NCT02181673 | Janssen Research & Development, LLC | Arthritis, Psoriatic | 2014-09-08 | PHASE3 |
| NCT03253796 | Merck Sharp & Dohme LLC | Spondyloarthritis | 2017-11-07 | PHASE4 |
| NCT02155335 | Merck Sharp & Dohme LLC | Ulcerative Colitis | 2014-07-01 | PHASE4 |
| NCT02414984 | Janssen-Cilag, S.A. | Rheumatoid Arthritis | 2015-03 | |
| NCT00973479 | Centocor, Inc.|Schering-Plough | Arthritis, Rheumatoid | 2009-09 | PHASE3 |
| NCT00299546 | Centocor, Inc.|Schering-Plough | Arthritis, Rheumatoid | 2006-02 | PHASE3 |
| NCT00487539 | Janssen Research & Development, LLC|Merck Sharp & Dohme LLC | Colitis, Ulcerative | 2007-08 | PHASE2|PHASE3 |
| NCT05242484 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2022-09-19 | PHASE2 |
| NCT00361335 | Centocor, Inc.|Schering-Plough | Rheumatoid Arthritis | 2006-09 | PHASE3 |
| NCT02186886 | Kliniken im Naturpark Altmuehltal | Ulcerative Colitis | 2014-06 | PHASE4 |
| NCT01288157 | Centocor, Inc. | Healthy Adult Chinese Males | 2010-09 | PHASE1 |
| NCT03733925 | Johnson & Johnson Private Limited | Spondylitis, Ankylosing|Arthritis, Psoriatic | 2019-01-07 | PHASE4 |
| NCT01962974 | Janssen Biotech, Inc. | Arthritis, Rheumatoid | 2013-10 | PHASE3 |
| NCT03773445 | Hospital San Carlos, Madrid|Hospital Universitario La Fe|Hospital Universitario 12 de Octubre|Hospital Universitario Ramon y Cajal|Gregorio Mara?ón Hospital|Complejo Hospitalario de Navarra|Hospital Universitario Fundación Alcorcón|Hospital Infanta Sofia|Hospital Clínico Universitario de Valencia|Puerta de Hierro University Hospital|Hospital Universitario La Paz|Hospital Universitario de Fuenlabrada|Merck Sharp & Dohme LLC | Ulcerative Colitis | 2019-03-01 | |
| NCT00488631 | Janssen Research & Development, LLC|Merck Sharp & Dohme LLC | Colitis, Ulcerative | 2007-09 | PHASE3 |
| NCT03596645 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2018-10-29 | PHASE3 |
| NCT01602302 | Medical University of Graz | Rheumatoid Arthritis | 2012-06 | PHASE4 |
| NCT02841176 | Imperial College Healthcare NHS Trust|Merck Sharp & Dohme LLC|Imperial College London | Psoriatic Arthritis | 2016-07 | NA |
| NCT00488774 | Janssen Research & Development, LLC|Merck Sharp & Dohme LLC | Colitis, Ulcerative | 2007-08 | PHASE2|PHASE3 |
| NCT01804166 | Janssen Scientific Affairs, LLC | Hepatosplenic T-Cell Lymphoma | 2013-03-21 | PHASE4 |
| NCT00265096 | Centocor, Inc.|Schering-Plough | Arthritis, Psoriatic | 2005-12 | PHASE3 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT03414502 | University of Nebraska | Rheumatoid Arthritis | 2007-12-10 | PHASE3 |
| NCT03043677 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Disease | 2016-04-01 | |
| NCT05405465 | University of Zurich|Merck Sharp & Dohme LLC | Ulcerative Colitis|Flare Up, Symptom | 2018-01-01 | |
| NCT03298542 | Janssen Research & Development, LLC | Pre-Symptomatic Type 1 Diabetes | 2017-10-16 | PHASE1 |
| NCT04725422 | Seattle Children´s Hospital|Boston Children´s Hospital, Boston, MA, USA|Hospital for Special Surgery, New York|Joseph M Sanzari Children´s Hospital, Hackensack University Medical Center, Hackensack, NJ, USA|Riley Children´s Hospital, Indianapolis, IN, USA|University of North Carolina, Chapel Hill, NC, USA|Royal Children´s Hospital|Hacettepe University|Bambino Gesù Children´s Hospital, Rome, Italy|University of British Columbia, Vancouver, BC, Canada|Meyer Children´s Hospital, Florence, Italy|Mansoura University|University of Utah, Salt Lake City, UT, USA|University of Iowa Carver College of Medicine, Iowa City, IA, USA|Ann & Robert H Lurie Children´s Hospital of Chicago|Palacky University Olomouc Institute of Molecular and Translational Medicine, Olomouc, Czechia|Alder Hey Children´s NHS Foundation Trust|University of Calgary | Chronic Nonbacterial Osteomyelitis|Chronic Recurrent Multifocal Osteomyelitis | 2018-08-01 | |
| NCT00975130 | Merck Sharp & Dohme LLC | Arthritis, Rheumatoid | 2009-09 | PHASE3 |
| NCT01217814 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2010-11 | PHASE2 |
| NCT04218565 | Wenjie Zheng | Behcet Syndrome|Uveitis | 2020-02-15 | PHASE2 |
| NCT03955861 | Belfast Health and Social Care Trust|British Medical Association|Psoriasis and Psoriatic Arthritis Alliance|Queen´s University, Belfast | Psoriatic Arthritis|Psoriasis|Enthesitis | 2019-02-14 | |
| NCT01988961 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2013-12 | PHASE2 |
| NCT02438787 | Janssen Research & Development, LLC | Axial Spondyloarthritis | 2015-07-31 | PHASE3 |
| NCT02687724 | University College Dublin | Colitis | 2016-06 | PHASE4 |
| NCT02092285 | Merck Sharp & Dohme LLC | Ulcerative Colitis | 2014-05-09 | PHASE4 |
| NCT00955279 | Centocor, Inc. | Sarcoidosis | 2009-11 | PHASE2 |
| NCT01900574 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2013-08-09 | PHASE1 |
| NCT00264550 | Centocor, Inc.|Schering-Plough | Rheumatoid Arthritis | 2005-12 | PHASE3 |
| NCT03885713 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2019-09-10 | PHASE4 |
| NCT05842213 | Alvotech Swiss AG | Rheumatoid Arthritis | 2023-03-30 | PHASE3 |
| NCT05164198 | Hanyang University Seoul Hospital|Linical Korea | Ankylosing Spondylitis|Axial Spondyloarthritis | 2022-01-15 | PHASE4 |
| NCT03632759 | Carla Greenbaum, MD|Juvenile Diabetes Research Foundation | Type 1 Diabetes Mellitus | 2018-08-15 | EARLY_PHASE1 |
| NCT02186873 | Janssen Research & Development, LLC | Ankylosing Spondylitis | 2014-09-03 | PHASE3 |
| NCT02425865 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | ULCERATIVE COLITIS | 2016-12 | PHASE4 |
| NCT05960578 | University of Washington|Janssen Scientific Affairs, LLC | Metastatic Castration-Resistant Prostate Carcinoma|Prostate Adenocarcinoma|Stage IV Prostate Cancer AJCC v8 | 2024-05-23 | PHASE2 |
| NCT01248780 | Centocor, Inc.|Schering-Plough | Rheumatoid Arthritis | 2010-09 | PHASE3 |
| NCT05669833 | University of Pennsylvania|Janssen Scientific Affairs, LLC | Psoriatic Arthritis | 2023-07-14 | PHASE3 |
| NCT01715896 | MedImmune LLC | Rheumatoid Arthritis | 2013-03 | PHASE2 |
| NCT02318667 | Merck Sharp & Dohme LLC | Colitis, Ulcerative | 2015-02-27 | PHASE4 |
| NCT01248793 | Centocor, Inc. | Ankylosing Spondylitis | 2010-10 | PHASE3 |
| NCT04610476 | University of Erlangen-Nürnberg Medical School | Psoriatic Arthritis|Withdrawal|Reduction | 2020-10-19 | PHASE3 |
| NCT01453725 | Merck Sharp & Dohme LLC|Johnson & Johnson | Spondylitis, Ankylosing | 2012-02-13 | PHASE3 |
| NCT03394586 | University of Zurich | Ulcerative Colitis|Flare Up, Symptom | 2018-01-01 | |
| NCT04531423 | Shanghai Mental Health Center | Major Depressive Disorder | 2020-10-01 | NA |
| NCT02437162 | Janssen Research & Development, LLC | Axial Spondyloarthritis | 2015-09-03 | PHASE3 |
| NCT07495644 | Assiut University | Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 2026-03-01 | |
| NCT01610947 | University Hospital, Montpellier | Spondyloarthritis | 2012-05-14 | NA |
| NCT04729296 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of South Florida | Diabetes Mellitus, Type 1 | 2021-07-01 | PHASE2 |
| NCT01526174 | House Research Institute|Janssen Services, LLC | Autoimmune Inner Ear Disease | 2012-03 | PHASE1|PHASE2 |
| NCT03945903 | Janssen Research & Development, LLC | Diabetes Mellitus, Type 1 | | |
| NCT03557853 | MSD Pharmaceuticals LLC | Ankylosing Spondylitis|Coxitis | 2016-06 | |
| NCT01426815 | University Hospital, Ghent|Janssen Biologics B.V. | Peripheral Spondylarthritis | 2012-03-13 | PHASE3 |
| NCT01668004 | Merck Sharp & Dohme LLC | Ankylosing Spondylitis | 2012-09-03 | PHASE4 |
| NCT01004432 | Janssen Biotech, Inc.|Merck Sharp & Dohme LLC | Arthritis|Arthritis, Rheumatoid|Autoimmune Diseases | 2009-12 | PHASE3 |
| NCT01258777 | Centocor, Inc. | Healthy Volunteers | 2010-10 | PHASE1 |
| NCT02390700 | Janssen Inc. | Rheumatoid Arthritis | 2015-02 | |
| NCT01295151 | Julia Brown | Rheumatoid Arthritis | 2011-08 | PHASE4 |
| NCT04200833 | Medical University of Graz | JIA Associated Uveitis | 2010-03-01 | |
| NCT00265083 | Centocor, Inc.|Schering-Plough | Spondylitis, Ankylosing | 2005-12 | PHASE3 |
| NCT00207740 | Centocor, Inc.|Centocor BV | Asthma | 2004-08 | PHASE2 |
| NCT00771251 | Janssen Pharmaceutical K.K.|Tanabe Pharma Corporation | Rheumatoid Arthritis | 2008-05 | PHASE3 |
| NCT00727987 | Janssen Pharmaceutical K.K.|Tanabe Pharma Corporation | Rheumatoid Arthritis | 2008-05 | PHASE3 |